Drug Information

Drug General Information
Drug ID
D01BGK
Former ID
DNC014022
Drug Name
1-(4-methoxyoxazol-2-yl)-7-phenylheptan-1-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529603]
Formula
C17H21NO3
Canonical SMILES
COC1=COC(=N1)C(=O)CCCCCCC2=CC=CC=C2
InChI
1S/C17H21NO3/c1-20-16-13-21-17(18-16)15(19)12-8-3-2-5-9-14-10-6-4-7-11-14/h4,6-7,10-11,13H,2-3,5,8-9,12H2,1H3
InChIKey
PLTPISAOEFIJFK-UHFFFAOYSA-N
PubChem Compound ID
44554788
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529603]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529603Bioorg Med Chem Lett. 2008 Nov 15;18(22):5842-6. Epub 2008 Jun 28.Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fattyacid amide hydrolase.
Ref 529603Bioorg Med Chem Lett. 2008 Nov 15;18(22):5842-6. Epub 2008 Jun 28.Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fattyacid amide hydrolase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.